When was PHARMASEAL founded?

PHARMASEAL was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is PHARMASEAL located?

PHARMASEAL is headquartered in Nottingham, United Kingdom.

Who is the current CEO of PHARMASEAL?

Daljit Cheema of PHARMASEAL. They have also founded 1 company.

Which legal entities is PHARMASEAL associated with?

PHARMASEAL is associated with PHARMASEAL International Limited.

How many employees does PHARMASEAL have?

As of Aug 31, 2026, the latest employee count at PHARMASEAL is 11.

Is PHARMASEAL a funded company?

PHARMASEAL is a funded company, having raised a total of $2.67M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 23, 2018.

When was the latest funding round of PHARMASEAL?

PHARMASEAL's latest funding was a $***** Seed round on Sep 07, 2020, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United Kingdom, the Life Sciences Tech sector has seen $2.44B in funding in 2026 to date.

Where does PHARMASEAL rank among its competitors?

PHARMASEAL ranks 5th amongst 58 active competitors, of which 7 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Flinn, which secured $20M in Feb, 2026.

Who are the top competitors of PHARMASEAL?

PHARMASEAL's top competitors include Flinn, Advarra and Freyr eTMF. Among them, Flinn secured the most recent funding round in February, 2026.

PHARMASEAL - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

PHARMASEAL is a SaaS-based B2B clinical trial governance platform for biopharmaceutical companies to manage their clinical trials. The company is developing a cloud-based trial management platform that allows clinical trial operators to manage and monitor their clinical trials in accordance with good clinical practice (GCP) regulatory standards. The company also plans to develop modules such as a patient safety tool & a license and regulatory management tool. The company has developed a product called Engility that assist with the clinical trail study and task management.

Website: www.pharmaseal.co/
Social
Email ID: *****@pharmaseal.co
Phone Number: +44 **********

Key Metrics

Founded Year

2016

Location

Nottingham, United Kingdom

Stage

Seed

Total Funding

$2.67M in 3 rounds

Latest Funding Round

Seed, Sep 07, 2020, $*****

Investors

Mercia & 18 more

Ranked

5^th among 58 active competitors

Employee Count

11 as on Aug 31, 2026

Similar Companies

Flinn & 68 more

View PHARMASEAL's full profile

PHARMASEAL is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PHARMASEAL International Limited CIN: 9993255 , Germany, Active		-	9 (As on Mar 31, 2021)

PHARMASEAL has raised a total funding of $2.67M over 3 rounds. Its first funding round was on Jan 23, 2018. PHARMASEAL has 3 institutional investors and 16 angel investors.

Here is the list of recent funding rounds of PHARMASEAL:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 07, 2020	5154125	Seed	5108490	6225449	6933806	7463899
May 03, 2019	6544290	Seed	9622028	6330605	9710311	4818409
Jan 23, 2018	3972013	Seed	6482477	1784101	Mercia	1429701

Access funding benchmarks and valuations. Sign up today!

View details of PHARMASEAL's funding rounds and investors

The founders of PHARMASEAL is Daljit Cheema. Daljit Cheema is the CEO of PHARMASEAL.

Here are the details of PHARMASEAL's key team members:

Daljit Cheema: Founder & CEO of PHARMASEAL.

View details of PHARMASEAL's Founder profiles and Board Members

PHARMASEAL's employee count trend

PHARMASEAL has 11 employees as of Aug 26. Here is PHARMASEAL's employee count trend over the years:

Uncover PHARMASEAL's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PHARMASEAL include Flinn, Advarra and Freyr eTMF. Here is the list of Top 10 competitors of PHARMASEAL, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Flinn 2022, Vienna (Austria), Series A	AI-enabled solution for manufacturers to automate compliance processes	$28.6M	HV Capital, Cherry Ventures & 23 others	61/100
2nd	Advarra 2017, Columbia (United States), Acquired	Provider of regulatory compliance consulting services	-	Linden Capital Partners, Northlane Capital Partners ... & 1 others	58/100
3rd	Freyr eTMF 2014, Princeton (United States), Unfunded	Cloud-based regulatory solutions for clinical trials	-	-	44/100
4th	PathWise 1993, American Fork (United States), Unfunded	Provider of online and instructor-led training for life science quality and compliance	-	-	41/100
5th	PHARMASEAL 2016, Nottingham (United Kingdom), Seed	Developer of a SaaS based platform for biopharmaceutical companies to manage their clinical trials	$2.67M	Mercia, Seedrs & 17 others	43/100
6th	Datapharm 1977, Leatherhead (United Kingdom), Late Stage	Provider of regulatory and compliance software for pharma and healthcare professionals	-	CGE Partners	36/100
7th	REMATIQ 2023, Berlin (Germany), Seed	AI-native regulatory system designed to streamline regulatory processes in the life sciences industry	$6.13M	Project A, Hello World & 3 others	35/100
8th	BridgeView Life Sciences 2018, Paoli (United States), Unfunded	Provider of a SaaS-based platform for management of life science companies	-	-	34/100
9th	Klaris 2024, London (United Kingdom), Seed	Provider of AI-powered compliance solutions for medical device manufacturers	$1.15M	Meridian Health Ventures, Mainspring Fund Services ... & 3 others	33/100
10th	Health Language 2000, Denver (United States), Acquired	Healthcare data solutions simplifying complex data for better health outcomes	$7.8M	eastriverventures.com, Lehman Brothers & 4 others	33/100